Infectious Diseases News and Research

RSS

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Immunologists aim to explore new avenues for immunotherapy of liver metastases

Four distinguished immunologists have been awarded one of the most generously funded research grants from the EU: the ERC Synergy Grant.

26 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

Calling on world leaders to recognize climate change and biodiversity loss as one indivisible global health emergency

Over 200 health journals across the world have come together to simultaneously publish an editorial calling on world leaders and health professionals to recognize that climate change and biodiversity loss are one indivisible crisis and must be tackled together to preserve health and avoid catastrophe.

25 Oct 2023

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Zika virus infection in pregnant rhesus macaques slows fetal growth and affects how infants and mothers interact in the first month of life, according to a new study from researchers at the California National Primate Research Center at the University of California, Davis.

25 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

Research suggests shorter isolation periods for children with COVID-19

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

24 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

Cockroaches provide clues to understanding immune system during pregnancy

Researchers are studying the dramatic physical transformation that some insects undergo to give birth to live young.

20 Oct 2023

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

The histopathologic alteration caused by SARS‑CoV‑2 on mammalian neurological systems.

20 Oct 2023

Experts from the research and innovation community invited to tackle anti-microbial resistance

Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).

20 Oct 2023

Study finds more mature gut microbiome in malnourished Nigerien children after antibiotic treatment

Malnutrition threatens the lives of millions of children under age 5, causing about 500,000 deaths per year in low- and middle-income countries.

19 Oct 2023

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

18 Oct 2023

Pan-coronavirus vaccine shows success in mouse studies

A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.

18 Oct 2023

More antibiotics not better for preventing infection after joint replacement surgery, study finds

Knee and hip replacements are increasing globally due to an aging population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next 7 years.

18 Oct 2023

Public health interventions prevented most SARS-CoV-2 introductions from leading to outbreaks

SARS-CoV-2, the causative agent of COVID-19, began impacting the U.S. in March 2020 with many schools and universities shifting to remote education by early April 2020 in response to the public health emergency.

17 Oct 2023

NIAID grant supports research aimed at improving outcomes for patients with Aspergillus infections

Aspergillus fumigatus is the major airborne fungus present indoors and outdoors that causes various diseases, the severity of which are dependent on an individual's immune status.

17 Oct 2023

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Southwest Research Institute has developed a unique technology (US20230242487A1) that enables the safe and efficient synthesis of organophosphorus nerve agent (OPNA) oxime antidotes.

17 Oct 2023

Paxlovid treatment provides protection against COVID-19 for both mother and child

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

16 Oct 2023

Infectious Diseases News and Research

Groundbreaking research advances understanding of how pathogens impact cancer

Immunologists aim to explore new avenues for immunotherapy of liver metastases

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

Calling on world leaders to recognize climate change and biodiversity loss as one indivisible global health emergency

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Epidemic: What good is a vaccine when there is no rice?

Research suggests shorter isolation periods for children with COVID-19

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Study reveals how tuberculosis bacteria form cords to resist antibiotics

Cockroaches provide clues to understanding immune system during pregnancy

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

Experts from the research and innovation community invited to tackle anti-microbial resistance

Study finds more mature gut microbiome in malnourished Nigerien children after antibiotic treatment

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Pan-coronavirus vaccine shows success in mouse studies

More antibiotics not better for preventing infection after joint replacement surgery, study finds

Public health interventions prevented most SARS-CoV-2 introductions from leading to outbreaks

NIAID grant supports research aimed at improving outcomes for patients with Aspergillus infections

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Paxlovid treatment provides protection against COVID-19 for both mother and child

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News